Most Read Articles
Audrey Abella, 16 Oct 2019
The PD-1* inhibitor nivolumab showed significant survival benefit and a favourable safety profile than taxane chemotherapy in patients with unresectable advanced or recurrent oesophageal squamous cell carcinoma (OSCC) refractory or intolerant to previous fluoropyrimidine- and platinum-based chemotherapy, according to the findings of ATTRACTION-3** presented at ESMO 2019.
03 Oct 2019
Early enteral nutrition (EEN) speeds up the recovery of gastrointestinal function after laparoscopic common bile duct exploration (LCBDE), according to a study. However, EEN also increases complications such as diarrhoea and abdominal distension.
01 Sep 2019
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
26 Sep 2019
Use of proton pump inhibitors contributes to increased risk of cholangitis, a large cohort study suggests.

HRQoL lower in kids with functional constipation

30 Oct 2019

Children with functional constipation suffer from compromised health-related quality of life (HRQoL), reports a recent meta-analysis.

Accessing the databases of Pubmed, PsycINFO and Embase, researchers retrieved 19 studies, corresponding to a cumulative sample of 2,344 children (aged 2–18 years; 48 percent female). Papers including patients with organic causes of constipation and that assessed HRQoL only after therapeutic treatment were ineligible for the analysis.

Thirteen of the included studies used the Paediatric Quality of Life Inventory and were eligible for meta-analysis. The resulting mean sample size-weighted pooled mean HRQoL score was 65.6. This was significantly lower than that in reference healthy populations (86.1; p<0.001).

Factors associated with quality of life in children with functional constipation included psychological maladjustment, longer disease duration and discomforting symptoms in the upper and lower gastrointestinal tract.

Parental factors likewise emerged as reliable predictors of child HRQoL. Maternal psychological distress and caregiver HRQoL, for instance, were both correlated with the child’s own HRQoL. The same was true for a poor relationship between the caregiver and the child, low socioeconomic status of the family, parental stress, and low educational level of the parents.

“We … recommend the use of HRQoL instruments in both research and clinical settings to assess the efficacy of treatments and follow-up,” said researchers. “We also identified modifiable risk factors, such as parental distress and duration of symptoms that may affect HRQoL of children with functional constipation.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 16 Oct 2019
The PD-1* inhibitor nivolumab showed significant survival benefit and a favourable safety profile than taxane chemotherapy in patients with unresectable advanced or recurrent oesophageal squamous cell carcinoma (OSCC) refractory or intolerant to previous fluoropyrimidine- and platinum-based chemotherapy, according to the findings of ATTRACTION-3** presented at ESMO 2019.
03 Oct 2019
Early enteral nutrition (EEN) speeds up the recovery of gastrointestinal function after laparoscopic common bile duct exploration (LCBDE), according to a study. However, EEN also increases complications such as diarrhoea and abdominal distension.
01 Sep 2019
A third of Clostridium difficile infection (CDI) patients with cirrhosis have been readmitted in a span of 30 days primarily due to recurrent CDI, a recent study has found. In addition, there is a high rate of mortality linked to CDI in patients with cirrhosis, in which a poor prognosis is predicted by decompensation and 30-day readmission.
26 Sep 2019
Use of proton pump inhibitors contributes to increased risk of cholangitis, a large cohort study suggests.